Pharmacokinetic Study of Ginsenoside 20(R)-Rh2 in Beagle Dogs by LC-ESI-MS
GU Yi,WANG Guang-ji,SUN Jian-guo,XIE Hai-tang,JIA Yuan-wei,XU Mei-juan,LV Hua,HUANG Cheng-rong,WANG Wei
DOI: https://doi.org/10.3969/j.issn.1009-2501.2006.03.004
2006-01-01
Abstract:AIM:To establish an LC-ESI-MS method for determination of ginsenoside 20(R)-Rh_2 and investigate its application to pharmacokinetic and absolute bioavailability study in Beagle dogs.METHODS: According to a randomized two-period crossover design,beagle dogs were given 1 and(0.1)(mg·kg~(-1)) 20(R)-Rh_2 via po and iv respectively.Drug plasma concentration was determined by LC-ESI-MS.Pharmacokinetic parameters were evaluated and absolute bioavailability was also calculated.RESULTS:The method was linear over the range of(0.5)-200(ng·ml~(-1))(R~2=(0.9998));The recovery of 20(R)-Rh_2 in dog plasma was more than 70%;Intra-and inter-batch precision,expressed as the relative standard(RSD) was less than 15%;After iv administration of 20(R)-Rh_2,the main pharmacokinetic parameters T_(1/2),CL,AUC_(0-∞) were(8.0)±(2.8) h,(0.1)±(0.03)(L·kg~(-1)·h~(-1)),(857.0)±(209.6)(ng·h·ml~(-1)) respectively;after po administration,the major pharmacokinetic parameters T_(max),C_(max),T_(1/2),AUC_(0-∞) were(2.6)±(1.3) h,(371.0)±(199.6)(ng·ml~(-1)),(5.8)±(2.6) h,(1215.7)±(598.6)(ng·h·ml~(-1)) respectively.The absolute bioavailability was(16.1)%±(11.3)% after the correction of dosage.CONCLUSION: The method described in this report was sensitive and specific,and suitable for pharmacokinetic studies of 20(R)-Rh_2 in dog.The absolute bioavailability of 20(R)-Rh_2 in dog was relative low.